Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001415889-22-003188
Filing Date
2022-03-18
Accepted
2022-03-18 16:30:59
Documents
1
Period of Report
2022-03-17

Document Format Files

Seq Description Document Type Size
1 form4-03182022_040336.html 4  
1 form4-03182022_040336.xml 4 13870
  Complete submission text file 0001415889-22-003188.txt   15155
Mailing Address 1040 SPRING ST SILVER SPRING MD 20910
Business Address 1040 SPRING ST SILVER SPRING MD 20910 3016089292
UNITED THERAPEUTICS Corp (Issuer) CIK: 0001082554 (see all company filings)

IRS No.: 521984749 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address
Business Address
MAHON PAUL A (Reporting) CIK: 0001231589 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-26301 | Film No.: 22752960